Where Global Innovation
and Capital Meet

Page 2

Li-S Energy celebrates market debut

Based on research at Deakin University, Li-S Energy has gone public on the Australian Stock Exchange after raising $25m in its initial public offering.

Sep 30, 2021

Lucid Diagnostics lines up IPO

Case Western Reserve University-linked Lucid Diagnostics is seeking an initial public offering that would net it up to $57.5m.

Sep 28, 2021

Oxford Nanopore sets IPO plans in motion

Oracle has signed up to be a cornerstone investor for Oxford Nanopore’s initial public offering, putting up half of the $410m target.

Sep 21, 2021

Context Therapeutics frames IPO plans

Based on research at Drexel University, Context Therapeutics is seeking to raise up to $21m in an initial public offering on Nasdaq.

Sep 15, 2021

Exscientia explores Nasdaq IPO

Dundee spinout Exscientia is continuing a busy fundraising year with a filing for an IPO in the US and a $35m concurrent private placement.

Sep 13, 2021

Icosavax lands on $182m IPO

UW's vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.

Aug 2, 2021

Tenaya tends to $180m IPO

The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.

Aug 2, 2021

IN8Bio initiates $40m IPO

IN8Bio, a University of Alabama spinout and cancer immunotherapy developer, has pulled in $40m through its IPO.

Jul 31, 2021

Duolingo brings in $521m IPO

Carnegie Mellon-linked Duolingo raised $521m in an upsized offering and saw its shares rise 36% on their first day.

Jul 29, 2021

© 2024 Mawsonia Ltd. All rights reserved.
test reg


Not yet subscribed?

See your subscription offers here